1-5 of 5
Eugene A. Zhukovsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CD19 Antibody MOR208 Efficiently Triggers Natural Killer Cell-Mediated Cytotoxicity Against Acute Lymphoblastic Leukemia Cells From Pediatric and Adult Patients

Christian Kellner, Eugene A Zhukovsky, Monika Brüggemann, Michael Kneba, MD, PhD, André Schrauder, Martin Schrappe, Roland Repp, Andreas Humpe, Martin Gramatzki, Matthias Peipp
Journal: Blood
Blood (2012) 120 (21): 1502.
https://doi.org/10.1182/blood.V120.21.1502.1502
Published: 2012
Journal Articles

Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies

Holly M. Horton, Matthew J. Bernett, Matthias Peipp, Erik Pong, Sher Karki, Seung Y. Chu, John O. Richards, Hsing Chen, Roland Repp, John R. Desjarlais, Eugene A. Zhukovsky
Journal: Blood
Blood (2010) 116 (16): 3004–3012.
https://doi.org/10.1182/blood-2010-01-265280
Published: 2010
Journal Articles

The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates

Jonathan Zalevsky, Irene W. L. Leung, Sher Karki, Seung Y. Chu, Eugene A. Zhukovsky, John R. Desjarlais, David F. Carmichael, Chris E. Lawrence
Journal: Blood
Blood (2009) 113 (16): 3735–3743.
https://doi.org/10.1182/blood-2008-10-182048
Published: 2009
Journal Articles

An Fc-Engineered Humanized Anti-CD40 Monoclonal Antibody, XmAb5485, Exhibits Potent Activity in Vitro and in Vivo against Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma

Eugene A. Zhukovsky, PhD, Holly Horton, Ph.D, Matthias Peipp, PhD, Erik Pong, BS, Matthew Bernett, PhD, Sher Karki, PhD, John Richards, PhD, Seung Chu, PhD, Roland Repp, MD, John Desjarlais, PhD
Journal: Blood
Blood (2008) 112 (11): 881.
https://doi.org/10.1182/blood.V112.11.881.881
Published: 2008
Journal Articles

Fc Engineered Anti-CD19 Monoclonal Antibodies with Enhanced In Vitro Efficacy Against Multiple Lymphoma Cell Lines.

Eugene A. Zhukovsky, PhD, Seung Chu, Ph.D., Matthew Bernett, Ph.D., Philip Hammond, Ph.D., Sher Karki, Ph.D., Wei Dang, Ph.D., Collin Edler, M.S., Nephi Polder, B.S., Cheryl Chan, B.S., Jonathan Jacinto, B.S., John Desjarlais, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4747.
https://doi.org/10.1182/blood.V108.11.4747.4747
Published: 2006